Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients’ T cell ferroptosis

BACKGROUND: Capecitabine (CAP) is a classic antimetabolic drug and has shown potential antirejection effects after liver transplantation (LT) in clinical studies. Our previous study showed that metronomic CAP can cause the programmed death of T cells by inducing oxidative stress in healthy mice. Fer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao, Wang, Zheng-Lu, Zhang, Sai, Kong, De-Jun, Yang, Rui-Ning, Cao, Lei, Wang, Jian-Xi, Yoshida, Sei, Song, Zhuo-Lun, Liu, Tao, Fan, Shun-Li, Ren, Jia-Shu, Li, Jiang-Hong, Shen, Zhong-Yang, Zheng, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280797/
https://www.ncbi.nlm.nih.gov/pubmed/37346150
http://dx.doi.org/10.3748/wjg.v29.i20.3084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280797/
https://www.ncbi.nlm.nih.gov/pubmed/37346150
http://dx.doi.org/10.3748/wjg.v29.i20.3084

Ejemplares similares